Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
about
Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium diseaseIdentification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain sheddingStructural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infectionDengue Virus (DV) Replication in Monocyte-Derived Macrophages Is Not Affected by Tumor Necrosis Factor Alpha (TNF- ), and DV Infection Induces Altered Responsiveness to TNF- StimulationCreation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonistEarly immune responses accompanying human asymptomatic Ebola infectionsImmune markers measured before treatment predict outcome of intensive phase tuberculosis therapyIdentification of key processes that control tumor necrosis factor availability in a tuberculosis granulomaThe locus of tumor necrosis factor-alpha action in lung inflammationA tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney diseaseA systems-theoretical framework for health and disease: inflammation and preconditioning from an abstract modeling point of viewA Randomized Controlled Trial of the Effects of Mindfulness-Based Stress Reduction (MBSR[BC]) on Levels of Inflammatory Biomarkers Among Recovering Breast Cancer Survivors.Targeting interleukin 18 with interleukin 18 binding protein.Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkersSoluble TNF receptors and kidney dysfunction in the elderly.Tumour necrosis factor, a key role in obesity?Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.Soluble cytokine receptors: basic immunology and clinical applications.The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans.Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.Variables that affect assays for plasma cytokines and soluble activation markers.Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women.Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers.Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.Dietary intake of trans fatty acids and systemic inflammation in women.Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.Long-term physical activity and inflammatory biomarkers in older adults.Characterization of recombinant extracellular domain of human interleukin-10 receptor.Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammationA glossary of circulating cytokines in chronic heart failure.Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational StudyPlasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trialSoluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
P2860
Q23920926-49A2171D-5DFF-4313-A676-B6FDFC7688DEQ24305047-BC363524-6562-4256-86B5-BF93FBDEACA8Q24671672-C18652BE-8D7E-43F8-A36D-EB453AB4AE50Q27480421-64AD9FD7-0165-4D64-B4C4-58F205D653FCQ27481475-F5029405-A382-409C-ADE3-532937FD4476Q27649040-1A5609DB-EC20-4B97-9F20-6E09F23D0C82Q28344889-857F21B9-176F-4979-BEED-8BD0AD216C30Q28396491-FB26B669-BCF3-4481-8972-715DB25DDEFBQ28473855-3B40016B-87DB-4306-BF63-40DEC18E3C1FQ28507632-C3F38EA6-45CC-4817-A974-C2AB81F1AF6FQ28588616-CC3F4D7A-52D7-4182-BFCB-8FAE6B63D9B2Q28755012-503B7C0E-8405-4A50-8845-4DF3C14DB4DDQ30252476-3A6DC76F-4C74-4F0C-B844-7B71F5C6F74FQ30951696-729CA0E7-B45D-40D9-B504-72422D565FABQ33434467-C8C8C6F3-6C6C-4341-9E58-2BBE6E6C2282Q33587452-7816C333-471E-444C-88CC-24F3EDFE24B4Q33660677-284005F1-567E-4874-83C0-7AD9415AF789Q33661065-D3BD787A-F166-46CD-9302-1CA5BF4F5719Q33681073-B2B07464-8D73-4397-8A8F-888A2EF43C68Q33688222-C1E9EC35-BE28-467A-86C1-4718ABF4AF0EQ33746430-669DC3B8-603C-46EE-81A8-3E9A751CC7BAQ33757212-8167D89C-6B3D-436E-B3E6-3EE5F02ECCDEQ33782360-8D76A3ED-8BC2-472E-9F96-CBF2515045C5Q33997552-0E7E3BCB-E310-417B-85B1-F902A2AA1EE5Q33998787-659B0C8F-B5E9-4868-AD36-7ADFEFFF3AB4Q34000080-0C65CA4A-D9BE-4AD1-942C-65C0F701A437Q34062601-55D89B5B-A01F-4A5D-AADF-A0C6083AB418Q34065967-FC924970-594B-4C31-9E02-95AC8DA3DD79Q34071322-B47BE710-2EC6-4B95-B9B0-D5D4CAE22EE4Q34130165-173C15C1-6B29-41FC-AF49-B04A88304554Q34146304-E1AC8E21-C235-4942-BC1C-FC3C5CD563EFQ34242309-9C6028DD-7BEC-40D3-A546-6A84B597FC3CQ34311415-405DD04B-797B-4CD7-95CD-9E8C7E02E8C2Q34332471-6BEC548A-E08A-4BD4-ABFC-BD03058A491CQ34398220-DC719E3A-9368-47B9-B803-7DD5D3EA0BC8Q34409484-8205541B-06A8-4DA1-9D32-9F01FE6A686EQ34669906-1F9D386B-A0F9-4912-8D38-7A2D70543152Q34882920-7C4B8EFE-CA9B-4052-94F2-811789F9B99CQ35078352-BF18D450-E206-46EC-97D8-8F8CC5E98D22Q35231318-34175174-C8E5-4F0E-824C-04D167751236
P2860
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@ast
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@en
type
label
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@ast
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@en
prefLabel
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@ast
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@en
P2093
P2860
P356
P1476
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
@en
P2093
P2860
P304
P356
10.1084/JEM.175.2.323
P407
P577
1992-02-01T00:00:00Z